A combination of levodopa and the extracerebrally acting decarboxylase inhibitor benserazide (ratio 4:1) (Madopar), was compared with levodopa alone in a controlled double-blind clinical multicenter trial on 94 patients with Parkinson's disease. During 4 months of therapy levodopa + benserazide prov
Madopar HBS and the decompensated phase of Parkinson disease
โ Scribed by T. Caraceni; N. Nordera; E. Lamperti; A. Lorizio
- Publisher
- Springer Milan
- Year
- 1989
- Tongue
- English
- Weight
- 587 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
To investigate the duration of a prodromal phase before the onset of the classic symptoms of idiopathic Parkinson's disease, the authors conducted a retrospective case-control study of 60 patients with Parkinson's disease and 58 age- and sex-matched control subjects, covering the decade preceding th
## Abstract The objectives of this study are to assess the level of disease severity associated with disability in Parkinson disease (PD) and the sequence of loss of independence in basic and instrumental activities of daily living (ADLs and IADLs). Six hundred eighteen patients with PD were evalua